As a conserved pathway that lies at the intersection between host defence and cellular homeostasis, autophagy serves as a rheostat for immune reactions. In particular, autophagy suppresses excess type I interferon (IFN-I) production in response to viral nucleic acids. It is unknown how this function of autophagy relates to the intestinal barrier where host-microbe interactions are pervasive and perpetual. Here, we demonstrate that mice deficient in autophagy proteins are protected from the intestinal bacterial pathogen Citrobacter rodentium in a manner dependent on IFN-I signalling and nucleic acid sensing pathways. Enhanced IFN-stimulated gene expression in intestinal tissue of autophagy-deficient mice in the absence of infection was mediated by the gut microbiota. Additionally, monocytes infiltrating into the autophagy-deficient intestinal microenvironment displayed an enhanced inflammatory profile and were necessary for protection against C. rodentium. Finally, we demonstrate that the microbiota-dependent IFN-I production that occurs in the autophagy-deficient host also protects against chemical injury of the intestine. Thus, autophagy proteins prevent a spontaneous IFN-I response to microbiota that is beneficial in the presence of infectious and non-infectious intestinal hazards. These results identify a role for autophagy proteins in controlling the magnitude of IFN-I signalling at the intestinal barrier.
T he trillions of bacteria and other infectious agents in the gastrointestinal tract are a constant source of immunostimulatory ligands. Although products originating from the microbiota benefit the host by inducing leukocyte differentiation, an unrestrained response is implicated in the chronic intestinal inflammation characteristic of inflammatory bowel disease (IBD). Mucins, antimicrobial peptides and immunoglobulins create separation between the epithelium and luminal bacteria, but microbial ligands can pass through this barrier and activate the immune system at both local and distal sites 1 . Elucidating cell-intrinsic mechanisms that prevent hyperactivation of the innate immune system is key to understanding how a tolerogenic environment is maintained.
The cellular pathway of autophagy (macroautophagy) is mediated by the coordinated action of conserved autophagy proteins and involves the sequestration of cytosolic material within a double membrane-bound vesicle termed the autophagosome. The contents, which can include organelles and protein aggregates, are degraded and recycled following fusion of the autophagosome with the lysosome. Increasing evidence indicates that autophagy dampens inflammatory reactions by targeting immune activators and signalling molecules for degradation 2 . For instance, autophagy inhibits type I interferon (IFN-I) production in response to sensing of viral RNA and DNA in the cytosol by RIG-I (retinoic-acid inducible gene I) and cGAS (cyclic GMP-AMP synthase), respectively [3] [4] [5] [6] [7] [8] . It is unknown whether autophagy inhibits IFN-I signalling in response to the microbiota. However, an important role for autophagy in suppressing reactions towards the gut microbiota is suggested by the association between a gene variant of ATG16L1 and IBD susceptibility 2 .
ATG16L1 forms a complex that mediates the attachment of phosphatidylethanolamine (PE) to the ubiquitin-like molecule LC3, a step that is essential for the proper formation and function of the autophagosome 2 . We have previously generated mice with a germline gene-trap mutation that leads to decreased Atg16L1 expression and reduced autophagy 9 . These Atg16L1 hypomorph (Atg16L1 HM ) mice develop intestinal abnormalities related to IBD on infection with murine norovirus (MNV) 9, 10 , an otherwise beneficial virus that persistently infects the intestine 11 . In contrast to this pathological response to a commensal-like virus, we found that Atg16L1 HM mice are remarkably resistant to intestinal infection by the model Gram-negative bacterial pathogen Citrobacter rodentium 12 . This increased protection was dependent on macrophage cell types and not lymphocytes, suggesting that autophagy has a critical role in limiting innate immune responses to intestinal bacteria. Here, we show that autophagy inhibition in the intestinal epithelium confers resistance to C. rodentium through an enhanced IFN-I response to the microbiota.
Results
Resistance conferred by Atg16L1 mutation is dependent on IFN-I. Our previous RNA deep-sequencing (RNA-seq) experiment showed that transcripts associated with innate immunity were enriched in intestinal samples collected from Atg16L1 HM mice compared with wild-type (WT) controls 12 . Among these transcripts were IFN-I stimulated genes (ISGs), reminiscent of observations made in autophagy-deficient tumour cells grown in culture 8, 13 . To test whether this increase in IFN-I signalling mediates resistance to infection, we crossed Atg16L1 HM mice with mice deficient in the IFN-I receptor (Ifnar -/-). Atg16L1 HM mice displayed > 100-fold reductions in the number of C. rodentium recovered in stool following oral inoculation compared with WT controls starting around day 9 post infection, with the greatest difference occurring at day 15 (Fig. 1a,b) . In contrast, bacterial burden in Atg16L1 HM Ifnar -/mice was similar to WT and Ifnar -/mice throughout the course of infection (Fig. 1a,b ), and protection from morbidity observed in Atg16L1 HM mice was lost in Atg16L1 HM Ifnar -/mice ( Fig. 1c ). Colonic crypt hyperplasia is associated with successful C. rodentium colonization 14 . Atg16L1 HM mice showed reduced levels of crypt hyperplasia and overall a lower intestinal pathology score, whereas the colons of Atg16L1 HM Ifnar -/mice appeared similar to WT mice ( Fig. 1d-f ). Atg16L1 HM , but not Atg16L1 HM Ifnar -/-, mice also displayed decreased C. rodentium dissemination to the liver (Fig. 1g) .
These results indicate that the benefit conferred by Atg16L1 mutation during C. rodentium infection is dependent on IFN-I signalling. Notably, Ifnar -/mice displayed similar bacterial burden and modestly reduced pathology compared to WT mice (Fig. 1f ). This indicates that IFN-I is typically dispensable or deleterious in a WT setting, but is selectively important in Atg16L1 HM mice.
Quantification of colonic lamina propria cells by flow cytometry at day 9 post infection did not reveal significant differences in the proportion of cytokine-producing lymphoid subsets when comparing infected WT, Ifnar -/-, Atg16L1 HM and Atg16L1 HM Ifnar -/mice ( Supplementary Fig. 1a -k). We also did not observe differences among genotypes in macrophages and dendritic cells, and neutrophils displayed a modest increase in Atg16L1 HM Ifnar -/mice ( Supplementary Fig. 2a -g). Because these results did not reveal ) . d-f, Representative H&E-stained colonic sections from WT (n = 8), Atg16L1 HM (n = 9), Ifnar −/− (n = 6) and Atg16L1 HM Ifnar −/− (n = 9) mice (d), quantification of crypt hyperplasia (e) and cumulative pathology score (f) on day 15 post infection from two independent experiments. Scale bar, 100 μ m. g, Bacterial burden in the liver measured as c.f.u. per gram of tissue. Data points in a,c and bars in b,e-g represent mean; dots in b,e and g represent individual mice. Error bars in c represent s.e.m. Analysis of variance (ANOVA) with Holm-Sidak multiple comparisons test was used to evaluate significance in all graphs. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (see Supplementary Table 2 for exact P values).
an obvious shift in leukocyte populations that explains the IFNdependent protection observed in Atg16L1 HM mice, we focused on other aspects of immunity such as the microbiota. We incorporated littermate controls in the above experiments, but this approach does not rule out the possibility that Ifnar deficiency ablates the enhanced resistance conferred by Atg16L1 mutation by reverting the microbiota of Atg16L1 HM mice to a WT-like state. We performed 16S rRNA sequencing of faecal microbiota isolated from mice representing the different genotypes used in this study, and included samples that were collected longitudinally from WT and Atg16L1 HM mice infected by C. rodentium to serve as a positive control for dysbiosis. Principal component analysis (PCA) and examination of the relative abundance of various taxa showed that samples from infected WT mice diverge from the other samples that cluster together ( Supplementary Fig. 3a ,c), similar to previous studies [14] [15] [16] . The abundance of Enterobactericiae (a family that includes C. rodentium) increased in WT mice during infection, and as expected based on the lower C. rodentium burden and crypt hyperplasia 14 , was less severe in Atg16L1 HM mice ( Supplementary Fig. 3b ). A comparison of uninfected Atg16L1 HM and Atg16L1 HM Ifnar -/mice indicated that Ifnar deletion does not significantly alter the microbiota of Atg16L1 HM mice. To examine how potential microbiota differences before C. rodentium infection impact the outcome of infection, germ-free (GF) mice were inoculated with stool isolated from uninfected WT, Atg16L1 HM , Ifnar -/and Atg16L1 HM Ifnar -/mice, which were then infected with C. rodentium. We did not detect differences in bacterial burden or morbidity when comparing mice reconstituted with microbiota from different genotypes ( Supplementary Fig. 3d-f ). These results indicate that host genotype, and not initial differences in microbiota composition, is the dominant determinant of C. rodentium susceptibility.
Other models of autophagy deficiency reproduce resistance to C. rodentium infection. Next, we examined whether the effect of Atg16L1 mutation can be reproduced by deficiency in other autophagy genes. LC3b -/mice that are deficient in one of several LC3 paralogues displayed reduced bacterial burden compared with WT controls ( Fig. 2a,b ). Recent studies have uncovered an innate immune function of ATG16L1 referred to as 'targeting by autophagy' proteins (TAG), which involves recruiting IFN-inducible GTPases to membranes associated with parasite replication and occurs independently of the autophagy protease ATG4B 17, 18 . Atg4b -/mice displayed an immense reduction in bacterial burden and were resistant to weight loss and other signs of disease ( Fig. 2c,d and Supplementary Fig. 4a,b ). Therefore, susceptibility to C. rodentium is unlikely to be mediated by TAG. The accelerated reduction in bacteria burden may reflect the more severe reduction in autophagy displayed by Atg4b -/mice than LC3b -/mice [19] [20] [21] [22] .
Deletion of Atg7 or Atg16L1 in the intestinal epithelium has been reported to confer susceptibility to C. rodentium 23, 24 , which initially led us to investigate the role of ATG16L1 in the haematopoietic compartment. However, deletion of Atg16L1 in myeloid cells (Atg16L1 flox/flox LyzM Cre ) did not reproduce resistance to C. rodentium 12 . Although we have shown that Atg16L1 deletion in dendritic cells increases T cell alloreactivity 25 , the same Atg16L1 flox/flox Cdllc Cre mice used in these studies displayed a similar response to C. rodentium infection as Atg16L1 flox/flox control mice ( Fig. 2e,f) . In contrast, mice in which Atg16L1 is deleted in the intestinal epithelium (Atg16L1 flox/flox Villin Cre ) showed a significant decrease in bacterial burden ( Fig. 2g,h) . It is possible that the discrepancy between our findings and the literature are due to differences in the health status of mice, particularly the presence of MNV, which we actively exclude from our mouse colonies and has been shown to alter immunity in Atg16L1 flox/flox Villin Cre mice 26. The T300A variant of ATG16L1 associated with IBD introduces a caspase-3 cleavage site in the protein [27] [28] [29] [30] . Homozygous knock-in mice harbouring the equivalent variant (Atg16L1 T316A ) display a potential compensatory increase in ATG16L1 compared with WT. However, we observed that full-length ATG16L1 protein is decreased in Atg16L1 T316A knock-in mice orally gavaged with PAC-1, a chemical activator of caspase-3 31 ( Supplementary Fig. 4c ). Thus, this model represents an opportunity to compare the effect of chemically induced ATG16L1 inhibition on C. rodentium infection, which would avoid genotype-dependent effects on the microbiota that precede infection. We found that PAC-1-treated Atg16L1 T316A mice, but not untreated mice, phenocopied Atg16L1 HM mice by displaying decreased bacterial burden in the stool and disease compared to PAC-1 treated WT mice (Fig. 2i,j and Supplementary  Fig. 4d ). Thus, multiple animal models indicate that ATG16L1 and autophagy proteins mediate susceptibility to C. rodentium.
Resistance conferred by Atg16L1 mutation is mediated by MAVS accumulation. Autophagy suppresses IFN-I signalling in part through the degradation of mitochondrial antiviral signalling protein (MAVS), a signalling intermediate that aggregates at the mitochondria to activate TBK-1 (tank-binding kinase 1) and IRF3 (interferon regulatory factor 3) downstream of the cytosolic RNA sensors RIG-I and MDA5 [6] [7] [8] . The ATG16L1 complex is recruited to mitochondria by NLRX1 and TUFM or COX5B 6, 7 . We found an increase in MAVS protein in whole colonic tissue collected from uninfected Atg16L1 HM mice compared with WT, and an increase in MAVS in whole colonic tissue from PAC-1-treated Atg16L1 T316A mice compared to PAC-1-treated WT, untreated Atg16L1 T316A and untreated WT colonic tissues ( Fig. 3a,b,d ). In the presence of cytoplasmic DNA, cGAS activates stimulator of interferon genes (STING) to signal through TBK-1 and IRF3; autophagy proteins regulate STING trafficking and the availability of DNA in the cytosol 5, [32] [33] [34] [35] . We found that STING protein levels were similar in WT and Atg16L1 HM colonic tissues ( Fig. 3a,c) . These findings are consistent with a proteomics analysis showing that MAVS, MDA5 (melanoma differentiation associated protein 5), RIG-I, IRF3 and phospho-TBK-1 accumulate in Atg5 -/and Atg7 -/-RAS-transformed cells, but STING does not 8 . Also, we found that Atg16L1 HM Mavs -/mice lose the superior protection observed in Atg16L1 HM mice ( Fig. 3e -g). Although STING was not increased in colonic tissue from Atg16L1 HM mice, we hypothesized that cytosolic DNA sensing could contribute to enhanced resistance because MAVS and STING share downstream signalling factors (IRF3 and TBK-1) that are activated in autophagy-deficient cells 8 . Indeed, Atg16L1 HM Sting -/mice also lose the protection conferred by Atg16L1 mutation (Fig. 3h -j). These results indicate that sensing of cytosolic nucleic acids is necessary for the increased resistance to C. rodentium conferred by Atg16L1 mutation.
Increased IFN-I signalling in Atg16L1 HM mice is dependent on the microbiota. Increased ISG expression in Atg16L1 HM mice is observed both before and during C. rodentium infection 12 . Such spontaneous activation could be explained by the microbiota. Although colons taken from conventional Atg16L1 HM and Atg4b -/mice displayed increased expression of Mx2 and Oasl2 in a manner dependent on IFNAR, the expression of these representative ISGs was reduced to WT levels in GF Atg16L1 HM mice (Fig. 4a,b and Supplementary Fig. 4f ). Mx2 expression was not increased in peripheral organs from Atg16L1 HM mice ( Supplementary Fig. 4e ), suggesting a local response. Immunohistochemistry (IHC) analyses confirmed that phospho-STAT1 (pSTAT1), another marker of IFN-I, is detected throughout the colonic epithelium and lamina propria of conventional Atg16L1 HM and Atg4b -/mice, and not nearly as detectable in conventional WT mice or GF WT and GF Atg16L1 HM mice ( Fig. 4c,d ). ISGs can also induce epithelial cell proliferation 36 . We found that Atg16L1 HM and Atg4b -/mice have an increase in Ki67 + proliferating colonic epithelial cells compared to WT, GF WT and GF Atg16L1 HM mice ( Fig. 4e,f) . These findings indicate that ATG16L1 suppresses IFN-I signalling downstream of local sensing of the microbiota.
Enhanced IFN-I response in Atg16L1 mutant mice protects against tissue injury. C. rodentium is avirulent in GF mice 37 . Thus, we wished to use a non-infectious model of intestinal injury to investigate the functional consequence of microbiotainduced IFN-I signalling in the gut. We found that Atg16L1 HM mice receiving the intestinal damaging agent dextran sodium sulfate (DSS) in drinking water displayed a striking reduction in lethality and weight loss compared with WT mice (Fig. 5a,b ). In contrast, GF Atg16L1 HM and GF WT mice were equally susceptible to DSS, even at a lower dose where survival is prolonged ( Fig. 5a and Supplementary Fig. 4g ). Atg16L1 HM Mavs -/mice displayed increased lethality and similar weight loss compared with Mavs -/controls ( Fig. 5c,d ). Also, Atg16L1 HM Sting -/mice displayed similar lethality compared with Sting -/mice ( Fig. 5e ,f). Thus, Atg16L1 mutation protects from DSS-induced injury in a MAVS, STING and microbiota-dependent manner.
Resistance conferred by Atg16L1 mutation is dependent on CCR2. We previously demonstrated that depletion of myeloid cells with clodronate-loaded liposomes abrogates the enhanced resistance to C. rodentium displayed by Atg16L1 HM mice 12 . This observation may reflect the essential role of CD11b + Ly6C hi monocytes recruited to the intestine through the chemokine receptor CCR2 38 . However, Atg16L1 flox/flox LyzM Cre mice that are autophagy-deficient An unpaired two-tailed t-test was used to evaluate differences between two groups where data were distributed normally with equal variance between conditions (a-h). ANOVA with Holm-Sidak multiple comparisons test was used to evaluate significance for experiments involving multiple groups (i,j). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (see Supplementary Table 2 for exact P values).
in myeloid cells are not resistant to C. rodentium 12 , and we did not detect a difference in the number of CD11b + Ly6C hi monocytes in the colons of Atg16L1 HM and WT mice ( Supplementary Fig. 5a,b) . Additionally, the IFN signature precedes monocyte recruitment because it is detectable in the absence of C. rodentium infection (Fig. 4a,b) . Therefore, the key role of monocytes identified in our previous study appears to be at odds with the findings in this manuscript implicating ATG16L1 function in the intestinal epithelium. One possible explanation is that properties of infiltrating monocytes, rather than their quantity, are altered on recruitment into the Atg16L1 mutant colon. RNA-seq analysis of fluorescence-activated cell sorting (FACS)-purified CD11b + Ly6C hi monocytes from the colon on day 9 post infection identified 812 genes with altered expression between Atg16L1 HM and WT mice, many of which have known functions in myeloid cell differentiation and function ( Fig. 6a, Supplementary Fig. 6 and Supplementary Table 1 ). Pathway analyses highlighted an enrichment in genes associated with metabolism, immune signalling and cell cycle regulation (Fig. 6b ). The metabolic signatures and cell cycle regulation may reflect enhanced differentiation into macrophages involved in resolution of infection and tissue repair 39 . Among the genes that were upregulated in monocytes collected from Atg16L1 HM mice were several associated with antimicrobial responses ( Supplementary Fig. 6 ). These results indicate that monocytes that migrate to the colon during C. rodentium infection acquire an altered gene expression profile in an Atg16L1 mutant setting. mice. An unpaired two-tailed t-test was used to evaluate differences between two groups (b,c). ANOVA with Holm-Sidak multiple comparisons test was used to evaluate significance for experiments involving multiple groups (d-j). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; NS, not significant (see Supplementary Table 2 for exact P values).
To validate gene expression data, we identified three surface receptors that were increased at the RNA level in monocytes derived from Atg16L1 HM mice, and which were assigned to the pathway 'inflammation and monocyte function' ( Supplementary  Fig. 6 ): XCR1, Galectin-9 and major histocompatibility complexclass II (MHC-II). All three receptors were increased on the cell surface of CD11b + Ly6C hi monocytes from day 9 infected Atg16L1 HM mice ( Supplementary Fig. 5c ). We next tested whether enhanced inflammasome activation leads to increased C. rodentium. ATG16L1 is a potent inhibitor of NLRP3 (NLR family pyrin-domain-containing 3) inflammasome activity in monocytic cells 40 , but we found NLRP3 to be dispensable for the protective effect of Atg16L1 mutation ( Supplementary Fig. 5d,e ). However, inflammasome complexes may function in a redundant manner during C. rodentium infection 41 , and the inflammasome gene Nlrc4 showed increased expression in infected Atg16L1 HM mice ( Supplementary Fig. 6 and Supplementary  Table 1 ). Therefore, we crossed Atg16L1 HM mice with Caspase1.11 -/double knockout mice to generally inhibit inflammasomes. Supplementary Table 2 for exact P values).
We found that Atg16L1 HM Caspase1.11 -/mice have similar bacterial burdens and disease scores as WT and Caspase1.11 -/controls, and do not display the superior protection observed in Atg16L1 HM mice ( Supplementary Fig. 5f-h) . Thus, although we identified an epithelial-intrinsic function of ATG16L1 linked to IFN-I signalling, other cell types and immune processes also acquire a heightened state of activity during C. rodentium infection.
To demonstrate that CD11b + Ly6C hi monocytes contribute to the enhanced immunity displayed by Atg16L1 HM mice, we generated Atg16L1 HM Ccr2 -/mice in which the chemokine receptor necessary for their recruitment during C. rodentium infection is absent 38 . WT, Ccr2 -/and Atg16L1 HM Ccr2 -/mice all displayed higher C. rodentium burden throughout the course of infection compared to Atg16L1 HM mice, with a 140-fold difference in bacterial burden between Atg16L1 HM Ccr2 -/and Atg16L1 HM mice at day 15 post infection (Fig. 6c,d) . The disease severity observed in these two groups was also markedly different ( Fig. 6e) . WT, Ccr2 -/and Atg16L1 HM Ccr2 -/mice all show decreased colon length ( Fig. 6f ) and increased dissemination to the liver (Fig. 6g ) compared to Atg16L1 HM mice at day 9 post infection. The intestinal inflammation at day 15 post infection in Ccr2 -/and Atg16L1 HM Ccr2 -/mice was comparable to WT mice, with Atg16L1 HM mice showing both reduced levels of crypt hyperplasia and intestinal pathology score ( Fig. 6h-j) . These results support a model in which monocyte recruitment contributes to an antimicrobial and tissue regenerative response downstream of Atg16L1 mutation in the colon. m. An unpaired two-tailed t-test was used to evaluate differences between two groups (b). ANOVA with Holm-Sidak multiple comparisons test was used to evaluate significance for experiments involving multiple groups (c-j). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (see Supplementary Table 2 for exact P values).
Discussion
Aberrant reactions to the microbiota are implicated in a range of disorders including IBD, yet a certain degree of responsiveness is necessary for host defence towards bona fide pathogens that access the gastrointestinal tract. We found that autophagy proteins in the colon suppress spontaneous activation of IFN-I signalling by the microbiota. Although our studies reveal a beneficial consequence of this enhanced activity, an IFN-I signature is a hallmark of several autoimmune diseases. Our findings indicate that mechanisms are in place to avoid spontaneous harmful IFN-I responses to the microbiota, which comes at the cost of antimicrobial immunity and tissue repair. Indeed, autophagy deficiency has been shown to cause inappropriate IFN-I signalling in the absence of DNaseII, a gene mutated in systemic lupus erythematosus 42 . Given this relationship between IFN-I and autoimmune antibody responses, it will be interesting to examine how autophagy deficiency impacts the generation of antibacterial IgG, previously shown to promote killing by phagocytes 43 .
We cannot rule out non-autophagy functions of ATG16L1, ATG4B and LC3B. However, our findings are consistent with the role of autophagy in mediating the degradation of MAVS [6] [7] [8] . Previous studies examining autophagy-deficient cells showed accumulation of MAVS and downstream signalling molecules shared with STING. The observation that deletion of either MAVS or STING compromises the benefit of Atg16L1 mutation suggests that both DNA and RNA moieties from the microbiota function as triggers. Our observations are further supported by the finding that RNA derived from the microbiota is recognized by RIG-I 44 . Recent studies indicate that metabolites from the microbiota potentiate IFN-I responses 45 , and that autophagy inhibits TLR3 and TLR4 by degrading the adaptor TRIF (TIR-domain-containing adapterinducing interferon-β ), which can converge on a similar signalling pathway as cytosolic sensors [46] [47] [48] . A future direction would be to examine how specific ligands gain access to the epithelium to trigger immune responses and identify the relevant members of the microbiota. Our conventional mice are free of known viruses, including MNV, but it will be important to determine whether viral members of the microbiota (including phages and endogenous retroviruses) contribute to the spontaneous IFN-I signalling we observe in autophagy-deficient mice.
The enhanced antimicrobial activity displayed by Atg16L1 HM mice is dependent on infiltrating monocytes, yet we show that ATG16L1 in the intestinal epithelium mediates this increased resistance. Our results are most consistent with a model in which a heightened state of immunity is established by microbiota-triggered IFN-I signalling due to the absence of autophagy in the intestinal epithelium, and then autophagy-sufficient monocytes that are recruited to this microenvironment in response to C. rodentium acquire enhanced activity that accelerates the resolution of infection. This model highlights how autophagy proteins in the parenchyma can affect the local environment in a way that alters activation of infiltrating immune cells.
The mechanism revealed by this current study supports the emerging theme that autophagy proteins have a central role in balancing host defence and inflammation 2 . In the presence of a shortterm threat to the gut, such as through C. rodentium infection or acute chemical injury, autophagy proteins have an adverse function. However, the benefit of autophagy inhibition is pathogen-specific, as demonstrated by the critical role of ATG5 and ATG16L1 in the epithelium during Salmonella enterica Typhimurium infection 49, 50 . Also, our previous study showing that a persistent strain of MNV, but not a strain that causes an acute infection, triggers IBD pathologies in Atg16L1 HM mice suggests that there is a long-term cost to autophagy deficiency 10 , and Atg16L1 HM mice are not universally protected from acute bacterial infection, as evidenced by their susceptibility to Staphylococcal infection 20 . In this context, it is notable that Atg16L1 T316A mice become resistant to C. rodentium upon caspase-3 activation, because we showed that the same Atg16L1 T316A mice are susceptible to MNV-induced pathology in the intestinal epithelium 26 . It is possible that this variant of ATG16L1 was retained in the human population because of its immunomodulatory properties, which can be beneficial or detrimental depending on the circumstance. We suggest that understanding the cost-benefit of autophagy function in immunity will inform the therapeutic application of autophagy modulators and predict how autophagy gene variants affect the course of inflammatory and infectious diseases.
Methods
Mice. Age-and gender-matched 8-to 12-week-old mice on the C57BL/6J background were used as WT controls unless stated otherwise and bred on site. Atg16L1 HM , Atg16L1 T316A , Atg16L1 f/f Villin cre , Atg16L1 f/f Cdllc cre and LC3b −/− mice have been described previously 12, 20, 25, 26 . Atg4b −/− mice were generously provided by Skip Virgin (Washington University School of Medicine) 51 . For single allele autophagy mutants, we used Atg16L1 HM/+ , Atg4b +/and LC3b +/− breeders to generate Atg16L1 HM/HM and Atg4b -/mice with their respective homozygous WT littermate controls (Atg16L1 +/+ and Atg4b +/+ ). Atg16L1 f/f Villin cre and Atg16L1 f/f Cdllc cre mice were generated along with Atg16L1 f/f littermates by breeding Cre-positive and negative Atg16L1 f/f mice. Ifnar −/− , Ccr2 −/− , Mavs −/− , Sting −/− and Caspase1.11 −/− mice were purchased from Jackson Laboratory and crossed to Atg16L1 HM mice to generate double mutants. For these compound mutants, we fixed the Atg16L1 HM allele first, then generated littermates that were homozygous knockout and wild type for the other allele. Using the Ifnar-deficient mice as an example, Atg16L1 HM/HM Ifnar +/mice were bred to each other through a trio mating scheme to generate Atg16L1 HM/HM Ifnar +/+ and Atg16L1 HM/HM Ifnar -/mice for experiments. To increase the number of mice analysed, experiments were supplemented with progeny generated from Atg16L1 HM/HM Ifnar -/breeder pairs. Mavs −/− mice were on a mixed C57BL/6 and 129/SvEv background and were bred to wild-type C57BL/6J mice to generate Mavs +/− mice, which were crossed to each other to generate controls for Atg16L1 and Mavs double mutants that were generated by breeding Atg16L1 HM Mavs +/− mice, similar to other compound mutants. Experimental groups were established based on genotype and infection status. All other aspects were randomized. Blinding was used during data collection by assigning numbers in place of genotype and infection status to mice in the studies. The number of animals used in the experiments in this study was estimated based on a power analysis with the following assumptions: standard deviation will be ~20% of the mean, P value will be under 0.05 when the null hypothesis is false, the effect size (Cohen's d) is between 1.0 and 2.0. The minimal number of mice required under these conditions ranges between 5 and 38 for in vivo experiments depending on the assay. Additionally, we have carefully chosen the sample size based on empirical evidence of what is necessary for interpretation of the data and statistical significance. All animal studies were performed according to approved protocols from the NYU School of Medicine Institutional Animal Care and Use Committee (IACUC).
Bacterial infection. C. rodentium strain DBS100 12 was grown overnight in Luria-Bertani broth with shaking at 37 °C and diluted 1:100 followed by an additional 3 h of growth until bacteria were at an optical density of 2. Bacterial density was confirmed by dilution plating. Mice were inoculated by oral gavage with 2 × 10 9 c.f.u. resuspended in 100 μ l PBS. Severity of disease was quantified through a scoring system in which individual mice received a score of 1 for each of the following: hunched posture, inactivity, ruffled fur and diarrhoea. Mice received an additional score between 0 and 2 for weight loss calculated as percent of initial body weight, with scores of 0 = 0-5%, 0.5 = 6-10%, 1 = 11-15%, 1.5 = 16-20% and 2 = greater than 20% loss. For quantification of bacterial shedding and dissemination, stool pellets or livers from individual mice were weighed, homogenized in PBS, and plated in serial dilutions on MacConkey agar. For caspase-3 activation, 50 mg kg −1 PAC-1 (APExBIO) was administered by oral gavage once a day for 3-5 days before C. rodentium infection.
Gnotobiotics. Previously described GF WT and Atg16L1 HM mice 12 were maintained in flexible film isolators, and absence of faecal bacteria and fungi was confirmed by aerobic culture in brain heart infusion, sabaraud and nutrient broth (Sigma), and qPCR for bacterial 16S and eukaryotic 18S ribosomal RNA genes through sampling of stool from individual cages in each isolator on a monthly basis. Mice were transferred into individually ventilated Tecniplast ISOcages for DSS treatment to maintain sterility under positive air pressure. For microbiota reconstitution experiments, stool slurries were prepared by resuspending 2-3 faecal pellets into 2 ml PBS and passing through a 40 μ M filter. GF mice were gavaged with 200 μ l of stool slurries before transfer into ISOcages. Intestinal flora was allowed to stabilize for three weeks before mice were infected with C. rodentium.
Tissue collection and microscopy. Haematoxylin and eosin (H&E)-stained colonic sections were prepared as previously described from mice that were euthanized by cervical dislocation to preserve the integrity of intestinal tissue 12 . Severity of tissue pathology was blindly quantified by a pathologist (R.X.). Mice received a pathology score between 0 and 3 for crypt abscess, hyperplasia, mucin depletion and for crypt loss and damage. A score of 0 = negative pathology, 1 = mild, 2 = moderate and 3 = severe pathology for the indicated fields. A length of at least 30 crypts per mouse was measured for crypt hyperplasia. Mean values were calculate for each mouse and used as individual data points. For IHC, formalin-fixed paraffin-embedded sections were deparaffinized online and antigen retrieved in Ventana Cell Conditioner 2 (Citrate). Endogenous peroxidase activity was blocked with hydrogen peroxide. Unconjugated polyclonal rabbit anti-mouse phospho-STAT1 (Cell Signaling Technology) and unconjugated rabbit anti-mouse Ki67 (M3062) (Spring Biosciences) were used and detected with antirabbit, horseradish peroxidase (HRP) conjugated multimer and visualized with 3,3-diaminobenzidene and enhanced with copper sulfate. For Ki67 quantification, 10 images were collected per mouse, and from each image three crypts were quantified. Mean values were calculated from 30 images for each mouse and used as individual data points. For p-STAT1 quantification, the number of positive cells was quantified throughout the whole colon section. Two sections were quantified per mouse with mean values calculated for each mouse and used as individual data points. Imaging was performed on the Evos FL Color imaging microscope. All analyses of slides were performed blind and quantified using ImageJ software.
RNA isolation and qPCR. Colonic tissue (2 mm) and 25 mg heart, liver, lung and mesenteric lymph node (MLN) were washed and cut open (when appropriate), then suspended in 700 μ l of RLT buffer (Mini RNeasy Kit) and homogenized using TissueRuptor (Qiagen). RNA was then isolated using the RNeasy Mini Kit (Qiagen). As per the manufacturer's instructions, DNase treatment was performed using an RNeasy DNase kit (Qiagen) and protocol. cDNA synthesis was performed using a ProtoScript M-MuLV First Strand cDNA synthesis kit (New England Biolabs) and Random Primers. qPCR was performed on a Roche480II Lightcycler using the following primers: Gapdh forward 5′ tggccttccgtgttcctac3′ , Gapdh reverse 5′ gagttgctgttgaagtcgca3′ , Mx2 forward 5′ ccagttcctctcagtcccaagatt3′ and Mx2 reverse 5′ tactggatgatcaagggaacgtgg3′ , OasL2 forward 5′ ggatgcctgggagagaatcg3′ and OasL2 reverse 5′ tcgcctgctcttcgaaactg3′ . The relative expression of the respective genes to Gapdh expression was calculated using the Δ Δ C T method and values were expressed as fold change normalized to uninfected WT mice.
Flow cytometry and RNA purification. To isolate immune cells from the lamina propria of the large intestine, small pieces of colon were washed with Hank's balanced salt solution (HBSS) and incubated at 37 °C with shaking in HBSS containing 1 mM dithiothreitol (DTT) and 5 mM EDTA for 15 min, 1 mM EDTA HBSS for 10 min, washed with HBSS, and then incubated in HBSS containing 0.1 U ml -1 dispase (Worthington Biochemical), 0.1 mg ml −1 DNase (Sigma-Aldrich) and 1 mg ml −1 collagenase (Roche) for 25 min. Digested tissues were filtered and washed twice with RPMI containing 10% fetal calf serum (FCS). Isolated cells were resuspended in 40% Percoll (Pharmacia Biotech), layered onto 80% Percoll, and centrifuged at room temperature at 2,200 r.p.m. for 20 min. Cells were recovered from the interphase and washed with RPMI containing 10% FCS. For T cell and innate lymphoid cell (ILC) subset profiling, cells were stimulated for 4 h with a cell stimulation cocktail of PMA, ionomycin, brefeldin A and monensin from eBioscience. Stimulated cells were stained for surface markers CD4 (RM4-5), CD8α (53-6.7), CD19 (6D5), CD11b (M1/70), TCRβ (H57-597) and CD90.2 (53-2.1), and intracellular markers IFN-γ (XMG1.2) and interleukin (IL)-17a (TC11-18H10.1) from Biolegend, and IL-13 (ebio13A) and IL-22 (1H8PWSR) from ebiosciences. A fixable live/dead stain from Biolegend was used to exclude dead cells. For profiling infiltrating monocytes, macrophages and dendritic cells, isolated cells were stained with antibodies against surface markers CD103(2E.7), CD11b (M1/70), CD11c(N418), CD115(9 − 4D2-1E4), Ly6C(HK1.4), Ly6G(1A8) F4/80(BM8), MHC-II(M5/114.15.2), Galectin-9(108A2), Xcr1(zet) and live/dead viability stain. All antibodies were from Biolegend. To sort inflammatory monocytes from the isolated lamina propria, cells were stained for 1 h at 4 °C for surface markers TCRβ (H57-597), CD19(6D5), CD103 (2E5), Ly6G(IA8), Cd11b (M1/70), Ly6C (HK1.4), FC block and Dapi for viability stain (all antibodies from Biolegend). Infiltrating monocytes were defined as Dapi − , TCRβ − , CD19 − , CD103 − , Ly6G − , Cd11b + and Ly6C + . Isolated lamina propria cells were resuspended in FCS then sorted directly into Trizol LS reagent (Life Technologies) using a Coulter MoFlo XDP flow cytometry as well as the expertise and services of the NYU Langone Cytometry and Cell Sorting Laboratory. An initial RNA purification process was performed by first adding 200 μ l of chloroform to cells sorted into trizol LS. The aqueous phase was collected and 7.5 μ g of linear acrylamide (Ambion) was added and gently mixed. RNA was precipitated with one volume of 100% isopropanol at − 20 °C for 1 h then pelleted at full speed for 30 min at 4 °C. Pellet was washed with 75% ethanol, then re-pelleted at full speed for 5 min at 4 °C. Pellet was dried for 15 min at room temperature and resuspended in 87.5 μ l of H 2 O. RNA was then isolated using an RNeasy Mini kit (Qiagen).
16S library preparation and sequencing analysis. DNA isolation from stool samples was performed using a NucleospinSoil Kit (Macherey-Nagel). Bacterial 16S rRNA gene was amplified at the V4 region using primer pairs 52 , and paired-end amplicon sequencing was performed on the Illumina MiSeq system. Sequencing reads were processed using the DADA2 pipeline in the QIIME2 software package 53 . Taxonomic assignment was performed against the Silva v132 database. Beta diversity was calculated using Bray Curtis distance. Principle coordinate analysis (PCoA) was performed on the Bray Curtis distance matrix and visualized with EMPeror 54 .
RNA deep sequencing. cDNA libraries were prepared with the Ovation Ultralow RNA-seq System V2 (NuGEN) and sequenced on Illumina's HIseq platform using a paired-end protocol at the NYU Genomics Core. On average, each sample yielded 32 million paired reads, which passed FASTQC quality control. Sequencing data were processed using the Tuxedo suite; reads were aligned with TopHat v2.1.1 against UCSC mm10 genome assembly, resulting in an average of 20 million aligned pairs per sample, and normalized read counts were calculated using Cufflinks v2.2.1 against the same reference genome. Differential gene expression was determined with Cuffdiff and gene ontology analysis performed using Qiagen's Ingenuity Pathway Analysis (IPA, Qiagen).
Western blot. Proximal colonic tissue (2 mm) was cut open and washed with PBS, then suspended in T-PER tissue protein extraction reagent (Thermo-Scientific) containing 10× protease inhibitor (Santa Cruz Biotechnologies) and homogenized using TissueRuptor. Tissue homogenate was then pelleted twice at 10,000g for 10 min at 4 °C. Protein concentration in the supernatant was measured by Bradford assay and reduced using 4× Laemmli buffer containing β -mercaptoethanol at 95 ° for 5 min. Due to the similar molecular weights of MAVS, STING, ATG16L1 and β -actin, parallel gels were equally loaded, and equivalently processed. For gel electrophoresis, 20-30 μ g of protein was run at 120 V for 1 h using a 4-12% gradient protein gel (BioRad), electrophoresis chamber and running buffer. Protein was then transferred to an Immun-Blot PVDF membrane through a BioRad semi-dry transfer apparatus for 1 h at 12 V constant. Membrane was incubated for 30 min with 5% non-fat dairy milk, and mouse anti-β -actin (Abcam) at 1:1,000, polyclonal rabbit anti-MAVS (Cell Signaling) at 1:1,000, mouse anti-ATG16L1 (MBL) at 1:1,000 and polyclonal rabbit anti-STING (Cell Signaling) at 1:1,000 were probed overnight at 4 °C. Specificity of MAVS and STING antibodies were confirmed using lysates from Mavs −/− and Sting −/− mice, respectively. Membranes were washed three times for 5 min and probed with secondary antibody rabbit anti-mouse HRP and goat anti-rabbit HRP antibodies for 1 h at room temperature. After additional washing, protein was then detected using Thermo Super Signal West Pico Chemiluminescent Substrate and imaged using a BioRad ChemiDoc XRS imaging system. β -Actin, ATG16L1 and STING band intensity were quantified using single band analysis while MAVS protein intensity was quantified using complete lane analysis.
DSS treatment.
Conventional mice were given 5% DSS (TdB Consultancy) for 7 days and both survival and weight loss was measured over time. GF mice were given 3% or 5% DSS and delivered in filter-sterilized water containing ampicillin (1 g l −1 ; American Bioanalytical), vancomycin (0.5 g l −1 ; MP biomedicals), neomycin (1 g l −1 ; Sigma), metronidazole (1 g l −1 ; Sigma) and 1% sucrose (Fisher). Antibiotic-containing water was replaced at least once a week. After DSS treatment, mice received regular or antibiotic-containing drinking water for the remainder of the experiment.
Statistical analysis.
All analyses except for RNA-seq data used Graphpad Prism v.7. An unpaired two-tailed t-test was used to evaluate differences between two groups where data was distributed normally with equal variance between conditions. An ANOVA with Holm-Sidak multiple comparisons test was used to evaluate experiments involving multiple groups. The log-rank Mantel-Cox test was used for comparison of mortality curves.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding author upon request. FASTQ files corresponding to the RNA-seq data have been deposited in a public database (RNA-seq GEO accession no. GSE115025, 16S GEO accession no. GSE116491).
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Experimental design 1. Sample size
Describe how sample size was determined.
The number of animals used in the experiments in this study is estimated based on a power analysis with the following assumptions: standard deviation will be ~20% of the mean, p-value will be under 0.05 when the null hypothesis is false, the effect size (Cohen's d) is between 1.0-2.0. The minimal number of mice required under these conditions ranges between 5-38 for in vivo experiments. Additionally, we have carefully chosen the sample size listed below based on empirical evidence of what is necessary for interpretation of the data and statistical significance.
Data exclusions
Describe any data exclusions.
No data was excluded from the analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
In all experiments, no attempts at replication failed.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Groups were established based off of genotype and infection status. All other aspects were randomized.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was used during data collection by assigning numbers in place of genotype and infection status to mice in the studies. Samples were also blindly assessed by a trained pathologist (R.X) nature research | life sciences reporting summary June 2017
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
All analysis except for RNA seq, flow cytometry, and western blot analysis were performed using Graphpad Prism v7. ImageJ 1.49v was used to histology measurements. FloJo v 10.2 was used to analyze all flow cytometry experiments. ImageLab software v 5.2 was used to analyze western blot experiments.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All unique materials used are readily available from the authors.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
